Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001062993-14-002195
Filing Date
2014-04-15
Accepted
2014-04-15 16:52:12
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K form10k.htm 10-K 394370
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 4648
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 4444
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 2136
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 2190
  Complete submission text file 0001062993-14-002195.txt   4687136

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cydi-20131231.xml EX-101.INS 384797
7 XBRL SCHEMA FILE cydi-20131231.xsd EX-101.SCH 115610
8 XBRL CALCULATION FILE cydi-20131231_cal.xml EX-101.CAL 51085
9 XBRL DEFINITION FILE cydi-20131231_def.xml EX-101.DEF 350851
10 XBRL LABEL FILE cydi-20131231_lab.xml EX-101.LAB 709652
11 XBRL PRESENTATION FILE cydi-20131231_pre.xml EX-101.PRE 392732
Mailing Address 401 ROSEMONT AVENUE - FREDERICK MD 21701
Business Address 401 ROSEMONT AVENUE - FREDERICK MD 21701 301-644-3901
Cybrdi, Inc. (Filer) CIK: 0000019002 (see all company filings)

EIN.: 952461404 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-09081 | Film No.: 14765528
SIC: 2836 Biological Products, (No Diagnostic Substances)